SEATTLE, April 9, 2015 /PRNewswire/ -- Omeros
Corporation (NASDAQ: OMER), a biopharmaceutical company committed
to discovering, developing and commercializing small-molecule and
protein therapeutics for large-market as well as orphan indications
targeting inflammation, coagulopathies and disorders of the central
nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief
executive officer, will present at the 14th Annual
Needham Healthcare Conference in New
York next week. The presentation is scheduled for
Tuesday, April 14 at 10:40am EDT.
The presentation will be webcast. The live and archived webcasts
can be accessed on the "Events" page under the Investors section of
the Company's website at www.omeros.com.
About Omeros Corporation
Omeros is a biopharmaceutical
company committed to discovering, developing and commercializing
small-molecule and protein therapeutics for large-market as well as
orphan indications targeting inflammation, coagulopathies and
disorders of the central nervous system. Derived from its
proprietary PharmacoSurgery® platform, the company's
first drug product, Omidria™ (phenylephrine and
ketorolac injection) 1%/0.3%, has been approved by the FDA for use
during cataract surgery or intraocular lens (IOL) replacement to
maintain pupil size by preventing intraoperative miosis (pupil
constriction) and to reduce postoperative ocular pain. Omidria is
currently under review for marketing approval by the European
Medicines Agency. Omeros has six clinical-stage development
programs focused on: complement-related thrombotic
microangiopathies; Huntington's disease, schizophrenia, and
cognitive impairment; addictive and compulsive disorders; and
preventing problems associated with surgical procedures. In
addition, Omeros has a proprietary GPCR platform, which is making
available an unprecedented number of new GPCR drug targets and
corresponding compounds to the pharmaceutical industry for drug
development.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omeros-to-present-at-the-14th-annual-needham-healthcare-conference-300063825.html
SOURCE Omeros Corporation